Eyebright Medical Ownership

688050 Stock   88.50  1.78  1.97%   
Eyebright Medical holds a total of 189.54 Million outstanding shares. Eyebright Medical Technology retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Eyebright Medical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Eyebright Medical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
The current year's Dividends Paid is expected to grow to about 64.4 M. As of November 29, 2024, Common Stock Shares Outstanding is expected to decline to about 106.7 M.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Eyebright Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Eyebright Stock Ownership Analysis

About 38.0% of the company shares are owned by insiders or employees . The company last dividend was issued on the 5th of June 2024. Eyebright Medical had 1.8:1 split on the 5th of June 2024. For more info on Eyebright Medical Technology please contact the company at 86 10 6074 5730 or go to https://www.ebmedical.com.

Eyebright Medical Outstanding Bonds

Eyebright Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Eyebright Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Eyebright bonds can be classified according to their maturity, which is the date when Eyebright Medical Technology has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in Eyebright Stock

Eyebright Medical financial ratios help investors to determine whether Eyebright Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eyebright with respect to the benefits of owning Eyebright Medical security.